Showing 34,879 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

PrEP

NIH Launches First Large Trial of a Long-Acting Injectable Drug for HIV Prevention

Editor's pick
National Institutes of Health
21 December 2016
Changing treatment

GlaxoSmithKline’s New Drug Challenges HIV Treatment Orthodoxy

Editor's pick
Wall Street Journal
20 December 2016
Global health initiatives

Trump Administration Puts the U.S. at a Crossroad for Global Health Aid

Editor's pick
New York Times
20 December 2016
Sexually transmitted infections prevention

Listerine gargle every day helps slow spread of gonorrhoea, study finds

Editor's pick
The Guardian
20 December 2016
New & experimental HIV treatments

Positive Results From First Phase III Studies of Investigational Two-Drug HIV Treatment Regimen

Editor's pick
Janssen press release
20 December 2016
Cardiovascular disease

African Americans taking ART have high incidence of illness associated with risk of cardiovascular disease

News
20 December 2016
TB diagnosis

IDSA Guidelines Recommend Newer Tests to Diagnose Tuberculosis

Editor's pick
IDSA
19 December 2016
Access to healthcare

Access to highly effective hepatitis C treatment in Portugal: A Community Perspective

Editor's pick
EATG
19 December 2016
HIV & criminal law

Greek court acquits HIV-positive women charged with 'transmitting the virus' via prostitution

Editor's pick
Athens News Agency - Macedonian Press Agency
19 December 2016
Pharmaceutical industry

Gilead’s Patent Loss to Merck Started With a Broken Friendship

Editor's pick
Bloomberg
19 December 2016
Experiences of stigma

This “First Dates” Contestant Was Told He Had To Reveal He Was HIV-Positive

Editor's pick
BuzzFeed News
19 December 2016
Access to healthcare

Hepatitis C patients 'go abroad for drugs'

Editor's pick
BBC Radio 4 (audio)
19 December 2016
Treatment outcomes & life expectancy

High rates of injury found among some HIV-positive people in B.C.

Editor's pick
CATIE
19 December 2016
Chemsex & recreational drug use

Chemsex Study Shows Urgent Need for Education amid Rising GHB Deaths

Editor's pick
Talking Drugs
19 December 2016
Neurological & cognitive problems

Link found between HIV treatment, neuronal degeneration

Editor's pick
Science Daily
19 December 2016
Health problems & ageing

Co-morbidities are common and rising among people with HIV in the US

News
19 December 2016
Pharmaceutical industry

Merck wins $2.54 billion in hepatitis C drug trial against Gilead

Editor's pick
Reuters
16 December 2016
Undetectable viral load & treatment as prevention

Five Reasons ‘HIV Undetectable’ Must Equal ‘Untransmittable’

Editor's pick
MarkSKing.com
15 December 2016
Clinical trials

The FDA Should Approve Drugs Based on Evidence, Not Emotions

Editor's pick
Slate
15 December 2016
Government, leadership & policy

Winners and Losers in the 21st Century Cures Act

Editor's pick
Poz
15 December 2016
Migrants, refugees & displaced people

HIV has no borders, but its treatment does. Why this needs to change

Editor's pick
The Conversation
15 December 2016
People with limited treatment options

People With Multidrug-Resistant HIV Can Now Start Treatment on the Experimental Drug Ibalizumab

Editor's pick
TheBody.com
15 December 2016
Resistance

High prevalence of resistance to zidovudine among people in sub-Saharan Africa experiencing virological failure with tenofovir-containing ART

News
15 December 2016
Economic & social inequality

Migration and age differences between male and female partners fuelling the HIV epidemic in South Africa

News
14 December 2016